FDA approves iron dextran formulation to avert shortage
Rockville, Md. -- The Food and Drug Administration (FDA) recently gave the green light to an iron dextran injectable formulation to alleviate a veterinary product shortage.
Rockville, Md. --
The Food and Drug Administration (FDA) recently approved an injectable iron dextran formulation to alleviate a veterinary product shortage.
The formulation, called Uniferon by Pharmacosmos of Watchung, N.J. (distributed by IVESCO of Iowa Falls, Iowa), is labeled for the prevention and treatment of iron deficiency anemia in baby pigs.
"In recent years there has been an inconsistent supply of injectable iron dextran products in the United States resulting in shortages," the agency says. "FDA determined the product was a medically necessary drug and issued letters of no objection to certain approved companies allowing them to temporarily import and distribute an injectable 200 mg/ml iron dextran product into the United States."
The approval should end any current shortages of injectable iron dextran, the agency adds.
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More
dvm360 announces winners of the Veterinary Heroes program
Published: September 6th 2024 | Updated: November 5th 2024This year’s event is supported by corporate sponsor Schwarzman Animal Medical Center and category sponsors Blue Buffalo Natural, MedVet, Banfield Pet Hospital, Thrive Pet Healthcare and PRN Pharmacal.
Read More
